Brief: Immunome Reports Q2 Net Loss Per Share Common Stock of $0.74
05/08/2022 13:21
Aug 5 (Reuters) - Immunome Inc IMNM.O :
* IMMUNOME REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* QTRLY NET LOSS PER SHARE OF COMMON STOCK, BASIC AND
DILUTED
$0.74
* AS OF JUNE 30, 2022, CASH AND CASH EQUIVALENTS TOTALED
$34.6
MILLION
Source text for Eikon: ID:nBw6YyKnba
Further company coverage: IMNM.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage